Romesh Subramanian
2020
In 2020, Romesh Subramanian earned a total compensation of $4.4M as Chief Scientific Officer at Dyne Therapeutics, a 962% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,395 |
|---|---|
| Option Awards | $2,818,520 |
| Salary | $371,875 |
| Stock Awards | $987,285 |
| Other | $6,900 |
| Total | $4,370,975 |
Subramanian received $2.8M in option awards, accounting for 64% of the total pay in 2020.
Subramanian also received $186.4K in non-equity incentive plan, $371.9K in salary, $987.3K in stock awards and $6.9K in other compensation.
Rankings
In 2020, Romesh Subramanian's compensation ranked 2,588th out of 13,090 executives tracked by ExecPay. In other words, Subramanian earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,588 out of 13,090 | 80th |
Division Manufacturing | 994 out of 5,621 | 82nd |
Major group Chemicals And Allied Products | 366 out of 2,254 | 84th |
Industry group Drugs | 314 out of 1,954 | 84th |
Industry Pharmaceutical Preparations | 229 out of 1,459 | 84th |
Source: SEC filing on April 14, 2021.
Subramanian's colleagues
We found two more compensation records of executives who worked with Romesh Subramanian at Dyne Therapeutics in 2020.